SMTL ID : 5y9l.1

Human kallikrein 7 in complex with 1,3,6-trisubstituted 1,4-diazepane-7-one

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

monomer

Ligands

1 x 8R3: 3-[2-[(3Z,6R)-6-[(5-chloranyl-2-methoxy-phenyl)methyl]-3-(dimethylhydrazinylidene)-7-oxidanylidene-1,4-diazepan-1-yl]ethanoylamino]benzoic acid(Non-covalent)

8R3.1: 19 residues within 4Å: Chain A: L.24, H.25, H.41, H.80, F.130, N.170, A.171, C.172, N.173, G.174, S.176, V.190, S.191, W.192, G.193, T.194, C.197, G.204, V.205 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:F.130, A:A.171, A:N.173, A:V.190 Hydrogen bonds: A:H.25, A:N.173, A:G.174, A:S.176

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 3 residues within 4Å: Chain A: K.43, S.69, R.71 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Murafuji, H. et al., Discovery and structure-activity relationship study of 1,3,6-trisubstituted 1,4-diazepane-7-ones as novel human kallikrein 7 inhibitors. Bioorg. Med. Chem. Lett. (2017)

Release Date

2017-11-29

Peptides

Kallikrein-7: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Kallikrein-7

Related Entries With Identical Sequence